Using boronolectin in MALDI-MS imaging for the histological analysis of cancer tissue expressing the sialyl Lewis X antigen

Chem Commun (Camb). 2011 Oct 7;47(37):10338-40. doi: 10.1039/c1cc11814e. Epub 2011 Aug 19.

Abstract

Certain carbohydrate-based biomarkers are known to correlate with cancer formation and progression. By targeting sialyl Lewis X, we have developed the first boronolectin-MS tag conjugate, which allows for MALDI-based imaging of cancer based on its cell surface carbohydrate.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Boron Compounds / chemical synthesis
  • Boron Compounds / metabolism*
  • Carcinoma, Renal Cell / metabolism
  • Carcinoma, Renal Cell / pathology*
  • Gene Expression Regulation, Neoplastic*
  • Kidney Neoplasms / metabolism
  • Kidney Neoplasms / pathology*
  • Lewis X Antigen / metabolism*
  • Molecular Imaging / methods*
  • Monosaccharides / chemical synthesis
  • Monosaccharides / metabolism*
  • Sialyl Lewis X Antigen
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / methods*

Substances

  • Boron Compounds
  • Lewis X Antigen
  • Monosaccharides
  • Sialyl Lewis X Antigen
  • boronolectin